Roggwil, February 8, 2023 – A market survey based on Google data has determined that tinniwell has taken the market leadership in its core market. With a market share of 36.73% in January 2023, all other therapies have been distanced. The further expansion of this market leadership is foreseeable, as in December 2022 and January 2023, two competitors each ceased their activities.

The number of providers of cognitive behavioral therapies, on the other hand, is constantly increasing. However, these are not competitors for tinniwell, as they do not focus on curing tinnitus. They only teach coping with tinnitus. Since tinnitus tends to become louder for most patients over the years, this therapeutic approach does not lead to a sustainable improvement for the patients.

++ About Resaphene Suisse AG

Resaphene Suisse AG, based in Roggwil, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.

++ Contact for inquiries:

Resaphene Suisse AG
Ms. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland

T. +41 714500668
a.rauterkus@resaphene.ch